★ Melbourne, Australia · Est. 2017

Australia Health
Industry Society
澳大利亚
大健康产业协会

A leading Australian platform for China–Australia health industry cooperation — connecting enterprises, institutions and innovators across two of the world's most significant health markets.

中澳大健康产业合作的澳大利亚重要平台,连接两国医疗健康领域的企业、机构与创新力量,共同推动高质量的中澳健康产业合作。

AHIS Logo
AU
Based
CN
Partner
2026
链博会
About the Society
关于协会

Who We Are

协会简介

The Australia Health Industry Society (AHIS) is a Melbourne-based industry association platform dedicated to advancing practical cooperation between the Australian and Chinese health industries. Since its incorporation in Victoria in 2017, AHIS has provided a structured platform for enterprises, institutions and professionals across health products, medical services, aged care, biotechnology, digital health and education.

澳大利亚大健康产业协会(AHIS)是立足墨尔本的行业协会平台,致力于推动澳中大健康产业之间的务实合作。自 2017 年在维多利亚州注册成立以来,AHIS 为健康产品、医疗服务、养老康养、生物科技、数字健康与教育等领域的企业、机构及专业人士提供结构化交流平台。

AHIS works with relevant Australia–China health industry and committee networks — including cooperation with the Medical and Healthcare Industry Committee of China Chamber of International Commerce (MHC of CCOIC) — through events, structured dialogue and program-based collaboration, where appropriate and subject to specific arrangements.

协会通过合作活动、行业会议与结构化对话,连接相关中澳健康产业及委员会网络(包括与中国国际商会医疗健康产业委员会(MHC of CCOIC)的合作);具体参与以适配性及项目安排为准。

Through our growing institutional and professional network across Melbourne's health, education, research and business sectors, AHIS connects Australian expertise with Chinese partners in a practical and structured way.

依托墨尔本高校、医院及科研机构的广泛网络,AHIS将澳大利亚健康产业生态系统的全方位资源引入中澳合作。

Founder & President

创会主席

AHIS was founded under the leadership of Yang Li, Principal Executive Officer of Mercury Institute of Victoria (CRICOS 03439M | RTO 41264) and Principal of NPG New Pathway Group — with a vision to build a sustainable, high-impact platform for China-Australia health industry cooperation.

AHIS由李杨创立并担任主席。李杨现任Mercury Institute of Victoria首席执行官(CRICOS 03439M | RTO 41264)及NPG新路径集团主席,致力于打造中澳大健康产业合作的可持续高质量平台。

Cooperation Networks

中澳合作网络

AHIS engages with relevant Australia–China health industry and committee networks through cooperation activities, events and structured dialogue, subject to suitability and specific program arrangements.

AHIS 通过合作活动、行业会议与结构化对话,连接相关中澳健康产业及委员会网络;具体参与以适配性及项目安排为准。

Registered in Australia

澳大利亚注册机构

Headquartered in Melbourne, Victoria, operating with governance and transparency aligned with Australian incorporated association requirements.

总部位于澳大利亚维多利亚州墨尔本,按照澳大利亚注册协会的治理与透明度要求运营。

Our Mission
核心使命

What We Stand For

我们的价值主张

🤝

Industry Bridge

产业桥梁

Connecting Australian health enterprises, researchers and innovators with China's rapidly growing health economy through bilateral cooperation activities.

通过双边合作活动,将澳大利亚健康企业、科研机构与中国数万亿规模的大健康经济体相连接。

🔬

Research & Innovation

产学研联动

Facilitating joint research, clinical knowledge exchange and academic-industry partnerships in traditional medicine, aged care and biomedical sciences.

推动传统医学、养老护理及生物医学领域的联合研究、临床知识交流与产学研合作。

🌿

Natural & Traditional Health

天然与传统医学

Advancing the internationalisation of Traditional Chinese Medicine and Australian natural health products within compliant, evidence-based frameworks.

在合规循证框架内,推动中医药国际化及澳大利亚天然健康产品的市场拓展。

🏥

Aged Care & Wellness

养老与大健康

Sharing best practices in aged care, chronic disease management and preventive wellness between Australia's mature sector and China's expanding elderly care market.

促进澳大利亚成熟养老体系与中国快速发展的老龄健康市场在最佳实践上的深度交流。

📊

Market-Entry Support

市场进入支持

Supporting companies to understand relevant market-entry considerations and pathway options through briefings, screening and coordination activities.

通过简报、快筛与协调活动,协助企业了解相关市场进入考虑因素及可能的路径选择。

🌐

Policy & Advocacy

政策倡导

Engaging government, regulators and international bodies to advance a bilateral policy environment supporting ethical, sustainable health industry cooperation.

积极与政府、监管机构及国际组织沟通,推动有利于中澳大健康产业可持续、合规合作的政策环境。

Flagship Initiative
旗舰合作项目

Cooperation & Projects

合作项目

AHIS leads and facilitates a growing portfolio of bilateral cooperation projects between Australian and Chinese health sector institutions — from strategic MOUs to research partnerships and market development initiatives.

AHIS积极主导并推进中澳大健康机构间的多元双边合作,涵盖战略合作备忘录、科研合作及市场开发等多个领域。

China International Supply Chain Expo — 链博会 2026

第四届中国国际供应链促进博览会(链博会)

AHIS is the designated Australian health industry coordination body for the Fourth China International Supply Chain Expo (链博会), where Australia is the Featured Guest Country. AHIS leads the curation of Australian health enterprise delegations, facilitates bilateral MOU signings, and represents Australian health industry interests at China's premier supply chain event — June 2026, Beijing.

AHIS担任第四届链博会(澳大利亚为主宾国)澳方大健康产业官方协调机构,负责组织澳方企业代表团、推动双边合作协议签署,并在北京链博会上代表澳大利亚大健康产业发声。

2026 Featured Guest
Country
主宾国

China-Australia Health Industry Cooperation Framework

中澳大健康产业合作机制

Strategic MOU between AHIS and the Medical and Healthcare Industry Committee of China Chamber of International Commerce (MHC of CCOIC) — establishing the foundational bilateral cooperation framework for joint activities and institutional exchanges.

AHIS 与中国国际商会医疗健康产业委员会(MHC of CCOIC)签署的战略合作备忘录,构建中澳双边合作的基础框架,涵盖联合活动及机构交流。

Sleep Health Industry Cooperation

中澳睡眠健康产业合作

Partnership with the Beijing Sleep and Health Promotion Association to develop joint research, product standards and market pathways in the fast-growing sleep health sector across both markets.

与北京睡眠健康促进协会合作,在快速增长的睡眠健康领域开展联合研究、产品标准制定及两国市场拓展。

TCM Internationalisation — Academic & Industry

中医药国际化产学研合作

Cooperation with Jiangxi University of Chinese Medicine to advance TCM research, education and commercial pathways through NPG New Pathway Group's Australian institutional network.

与江西中医药大学合作,依托NPG新路径集团的澳大利亚机构网络,推动中医药科研、教育及商业化路径国际化。

Key Partners
主要合作伙伴

Our Institutional Network

机构合作网络

🏛️

Medical and Healthcare Industry Committee of China Chamber of International Commerce (MHC of CCOIC)

中国国际商会医疗健康产业委员会(MHC of CCOIC)

Primary Chinese institutional partner for bilateral health industry cooperation and 链博会 coordination.

中澳大健康产业合作及链博会协调工作的中方主要机构合作伙伴。

🎓

Jiangxi University of Chinese Medicine

江西中医药大学

Academic partner for TCM internationalisation, joint research and educational exchange programs.

中医药国际化、联合科研及教育交流项目的学术合作伙伴。

🏫

Mercury Institute of Victoria

维多利亚Mercury学院

Australian RTO and CRICOS provider (03439M | RTO 41264) contributing academic credentialing and training pathways.

澳大利亚注册培训机构及CRICOS院校(03439M | RTO 41264),提供学术认证及培训路径支持。

Latest News
最新动态

CISCE 2026 — Outcomes

链博会成果公告

Press Release · 24 June 2026 · Beijing
新闻发布 · 2026年6月24日 · 北京

AHIS Makes Its Debut at China International Supply Chain Expo

澳大利亚大健康产业协会 AHIS 首次亮相链博会

链博会
CISCE 2026

On 24 June 2026, at the Fourth China International Supply Chain Expo (CISCE) in Beijing, AHIS co-hosted the MHC of CCOIC Working Session and China-Australia Health Industry Exchange Salon — marking Australia's debut as Guest Country of Honour at CISCE and establishing a formal bilateral cooperation mechanism between the two organisations.

AHIS President Yang Li and CCOIC Department of Industrial Cooperation Deputy Director Lin Shenghong signed the cooperation framework agreement. Australian expert presentations covered TCM internationalisation, regenerative medicine, health consumer products compliance, and natural health products.

Witnessed by representatives of Jiangxi University of Chinese Medicine, Fujian Provincial Trade Promotion Council, Beijing Geriatric Hospital, International Regenerative Medicine, and Renhe Group. A separate MOU between AHIS and the Beijing Sleep and Health Promotion Association was signed at the same ceremony.

📋
Cooperation Framework Signed
AHIS × MHC of CCOIC bilateral mechanism established
🤝
MOU — Sleep Health
AHIS × Beijing Sleep and Health Promotion Association
🎙️
Expert Presentations
5 topics covering TCM, regenerative medicine, health products & compliance
Full Press Release (Chinese) 完整新闻稿
Photo Gallery
现场图集

CISCE 2026 — In Pictures

链博会现场图集

AHIS Makes Its Debut at the China International Supply Chain Expo

Cooperation Mechanism Established with the MHC of CCOIC

24 June 2026 · China International Exhibition Centre (Shunyi), Beijing · Fourth China International Supply Chain Expo (CISCE)

On 24 June 2026, during the Fourth China International Supply Chain Expo (CISCE) in Beijing, the MHC of CCOIC Working Session and China-Australia Health Industry Exchange Salon was successfully held at the China International Exhibition Centre (Shunyi). Co-hosted by the Medical and Healthcare Industry Committee of China Chamber of International Commerce (MHC of CCOIC) and the Australia Health Industry Society (AHIS), the event marked Australia's debut as Guest Country of Honour at CISCE — opening a new chapter in China-Australia health industry cooperation.

Australian Expert Team Showcases Industry Strengths and Cooperation Opportunities

During the session, the AHIS expert delegation delivered presentations on Australia's health industry landscape, pathways for TCM internationalisation and localisation, health consumer product cooperation channels, regenerative medicine research and clinical service opportunities, and compliance frameworks for natural health products in international markets — demonstrating Australia's industry advantages, regulatory expertise, and genuine intent for bilateral cooperation with China.

AHIS President Yang Li stated that Australia possesses advanced research and development capabilities, a rigorous regulatory system, and extensive international cooperation experience in the health industry. Leveraging the national-level cooperation platform established through the Healthy Living Supply Chain strand at CISCE, AHIS looks forward to deepening engagement with Chinese industry partners in TCM internationalisation, regenerative medicine, health product regulatory compliance, and industry resource matching — achieving complementary strengths and mutual benefit.

Cooperation Framework Signed — Establishing a Standing Bilateral Platform

A formal signing ceremony was held during the event. CCOIC Department of Industrial Cooperation Deputy Director Lin Shenghong and AHIS President Yang Li signed the cooperation framework agreement on behalf of their respective organisations, marking the formal establishment of a standing bilateral cooperation mechanism for China-Australia health industry engagement. Representatives from Jiangxi University of Chinese Medicine, Fujian Provincial Council for the Promotion of International Trade, Beijing Geriatric Hospital, International Regenerative Medicine, and Renhe Group witnessed the signing.

Simultaneously, the Beijing Sleep and Health Promotion Association and AHIS signed a separate Memorandum of Understanding, witnessed jointly by Chinese and Australian industry representatives. This signing represents a significant outcome achieved in the context of Australia's debut as Guest Country of Honour at CISCE, and marks a key step for AHIS in deepening cooperation with China and expanding bilateral health industry channels.

Both parties will leverage the CISCE platform to deepen ongoing collaboration among member organisations in technology development, industry exchange, regulatory information sharing, talent development, and market cooperation — building a more stable, practical, and effective two-way channel for the China-Australia health industry.

Looking Ahead — Continuing to Build China-Australia Health Industry Bridges

AHIS has indicated it will treat this signing as a starting point, leveraging its resource integration strengths in Australia's health industry to work closely with the MHC of CCOIC in building a standing communication and exchange platform for industry stakeholders on both sides.

Going forward, AHIS will continue facilitating connections between Australian enterprises and the Chinese market, while welcoming Chinese enterprises to explore health industry investment, exchange, and cooperation opportunities in Australia — across health consumer products, TCM internationalisation, digital health, regenerative medicine, aged care, and natural health products — contributing to the high-quality development of the global health industry.

— END —

澳大利亚大健康产业协会 AHIS 首次亮相链博会

与中国国际商会医药健康产业工作委员会建立中澳大健康产业合作机制

2026年6月24日 · 北京中国国际展览中心(顺义馆) · 第四届中国国际供应链促进博览会

2026年6月24日,第四届中国国际供应链促进博览会(链博会)期间,由中国国际商会医药健康产业工作委员会与澳大利亚大健康产业协会(AHIS)共同主办的"医药健康产业工作委员会工作会暨中澳大健康产业合作交流沙龙"在北京中国国际展览中心(顺义馆)成功举行。澳大利亚首次以主宾国身份正式参与链博会,AHIS以此为重要契机,携手中国伙伴共同开启中澳大健康产业合作新篇章。

澳方专家团深度分享,展现产业优势与合作机遇

活动期间,AHIS专家团围绕澳洲大健康产业现状、中医药国际化机会与本土化准入路径、澳洲健康消费品与中澳健康产业渠道合作、澳洲再生医学研究与临床研究服务合作机会、澳洲天然健康产品的合规化与国际市场拓展等主题进行了专题分享,全面展示了澳大利亚在大健康领域的产业优势、监管经验与对华合作诚意。

AHIS会长李杨表示,澳大利亚在大健康产业领域拥有先进的研发能力、严谨的监管体系和丰富的国际合作经验。此次借助链博会健康生活链板块搭建的国家级合作平台,AHIS期待与中国产业伙伴在中医药国际化、再生医学、健康消费品合规准入、产业资源对接等领域开展更加深入的交流与合作,实现优势互补、互利共赢。

签署合作机制,构建中澳大健康产业常态化对接平台

活动期间举行了中澳大健康产业合作签约仪式。中国国际商会产业部副部长林胜鸿与AHIS会长李杨代表双方签署合作机制协议,标志着中澳大健康产业合作正式建立常态化对接机制。江西中医药大学、福建省贸促会、北京老年医院、国际再生医学、仁和集团等单位代表共同见证签约。

同时,北京睡眠与健康促进会与AHIS同步签署合作备忘录,中澳双方产业代表同台见证。此次签约是在澳大利亚首次以主宾国身份参与链博会背景下取得的重要合作成果,也是AHIS深化对华合作、拓展中澳大健康产业交流渠道的关键一步。

双方将依托链博会平台,推动会员单位在技术研发、产业交流、合规信息沟通、人才培养、市场合作探索等领域持续深化合作,为中澳大健康产业界建立更加稳定、务实和高效的双向对接通道。

展望未来,持续搭建中澳大健康产业合作桥梁

AHIS表示,将以此次签约为起点,充分发挥协会在澳大利亚大健康产业领域的资源整合优势,与中国国际商会医药健康产业工作委员会紧密协作,为中澳双方产业界搭建沟通交流的常态化平台。

未来,AHIS将持续推动澳大利亚企业对接中国市场,同时欢迎中国企业赴澳探索大健康产业投资、交流与合作机会,围绕健康消费品、中医药国际化、数字健康、再生医学、养老康养、天然健康产品等方向开展更广泛的产业合作,共同为全球大健康产业高质量发展贡献力量。

—— 完 ——

Membership
会员申请

Join AHIS

申请加入协会

AHIS welcomes Australian and Chinese health enterprises, research institutions, clinicians and investors who share our vision of sustainable, high-quality China-Australia health industry cooperation.

AHIS欢迎中澳两国大健康企业、科研机构、医疗专业人员及投资者加入,共同推动中澳大健康产业的高质量、可持续合作。

Individual Member
个人会员
A$330 / year2026 Founding Rate A$250
每年 A$3302026 创始会员价 A$250
Get close to the action. Individual membership connects healthcare professionals and researchers to the people, ideas and events driving Australia–China health cooperation.
靠近行动核心。个人会员将医疗专业人员与科研人员连接到推动中澳健康合作的人脉、思想与活动。
  • Member-rate access to events and briefings以会员价参与活动及简报
  • AHIS member directory listing收录于会员名录
  • Industry newsletter & policy updates行业资讯及政策动态
  • Networking introductions, where appropriate在适当情况下提供人脉对接
  • Eligibility to join professional committees以个人身份参与专业委员会资格
Programs & Sponsorship
战略合作项目与赞助

Strategic Programs & Sponsorship

战略合作项目与赞助

Beyond membership: high-impact ways to lead, sponsor and grow within the Australia–China health space. These are programs, services and sponsorships — not association membership — and carry no voting or governance rights.

会员之外:在中澳健康领域引领、赞助与成长的高价值方式。本表为项目、服务与赞助,非协会会员身份,不附带投票权或治理权。

12-Month Engagement12个月项目
Strategic Corporate Program
战略企业合作项目
From A$9,8002026 Founding Rate from A$6,800 · by application
A$9,800 起2026 创始价 A$6,800 起 · 审核制
Membership gets you in the room. This puts you closer to the front — a focused 12-month engagement with a dedicated liaison, defined deliverables and priority visibility. Scope set in a separate agreement.
会员让你进入房间,本项目让你更靠近前排——聚焦的 12 个月合作,配专属联络人、明确交付范围与优先曝光,范围以单独协议为准。
Patronage荣誉支持
Founding Patron
创始荣誉支持单位
From A$25,000limited · no discount
A$25,000 起限量 · 不打折
Be one of the names that helped set the table. Senior recognition across AHIS's 2026 flagship events, forums, dinners and bilateral health cooperation activities — visible as an early institution backing this renewed platform.
成为帮助摆好这张桌子的名字之一。于 AHIS 2026 年旗舰活动、论坛、晚宴及双边健康合作活动中获高规格鸣谢,作为支持平台重新启动的早期机构被展示。
Event Sponsorship活动赞助
CISCE Program Sponsor
链博会项目赞助
A$5,000 / 10,000 / 20,000Bronze · Silver · Gold
A$5,000 / 10,000 / 20,000铜 · 银 · 金
Put your brand on the bilateral stage. Sponsor AHIS's CISCE-related session and activities and place your organisation in front of the audience defining Australia–China health trade.
让品牌登上双边舞台。赞助 AHIS 链博会相关会议与活动,让贵机构出现在定义中澳健康贸易的人群面前。
Event Sponsorship活动赞助
Roundtable / Forum Sponsor
圆桌 / 论坛赞助
From A$5,000per event
A$5,000 起单场
Anchor a focused conversation. Sponsor an AHIS roundtable or forum and place your brand at the centre of a high-value industry discussion.
成为一场聚焦对话的核心。赞助 AHIS 圆桌或论坛,让品牌处在高价值行业讨论的中心。
Program Support项目支持
Professional Committee Supporter
专业委员会支持单位
A$3,000 – 8,000 / yearsubject to AHIS approval
每年 A$3,000–8,000须经 AHIS 审核
Back the work that's shaping the industry. Support a professional committee's program and gain recognition and priority participation in its activities. Participation remains subject to AHIS approval and committee suitability.
支持正在塑造行业的工作。支持某专业委员会项目,获得鸣谢及活动优先参与权;具体参与须经 AHIS 审核,并以委员会适配性为准。
Professional Service专业服务
Delegation Package
代表团服务包
A$3,000 – 9,000per company, per delegation
A$3,000–9,000每家企业 / 每次代表团
Don't just attend — arrive prepared. We coordinate your company's place in an AHIS delegation: itinerary, meeting coordination and bilingual support, so every meeting has a clearer purpose. Travel and accommodation excluded.
不只是参加,而是有备而来。我们协调贵司参与 AHIS 代表团:行程、会面协调与中英文支持,让每次会面更有目标。差旅住宿不含。
Professional Service专业服务
Market Entry Screening
市场准入评估
Quick Screening from A$2,500Deep Assessment up to A$6,000
快筛 A$2,500 起深度评估至 A$6,000
Know where you stand before you spend. Our screening assesses your readiness for the Australian market and maps the pathways that may apply — such as Listed Medicine, food, cosmetic, medical device or other pathways. Not regulatory approval; does not guarantee market entry.
投入之前,先看清位置。评估贵司进入澳洲市场的就绪度,并梳理可能适用的路径——例如 Listed Medicine、食品、化妆品、医疗器械或其他路径。非监管批准,不保证市场准入。

2026 Founding Member Rate is available to approved early members and is held for the member's first two membership years; standard fees apply from the third year. All prices are in AUD and exclusive of GST unless otherwise stated. For overseas applicants, AHIS issues a formal AUD tax invoice after approval and provides payment instructions individually.

2026 创始会员价仅适用于经审核通过的早期会员,锁定首两个会员年度;第三年起适用标准会员费。所有价格以澳元计,除另有说明外均不含 GST。海外申请机构经审核通过后,AHIS 出具澳元正式税务发票并另行提供付款指引。

Important. AHIS is an Australia-based industry association platform — not a government body, and it does not represent any government. Membership, sponsorship and program benefits are opportunities, access and introductions, subject to suitability and availability. AHIS does not provide medical, legal, investment, taxation or migration advice, and does not guarantee any commercial, regulatory (including TGA / AHPRA), investment, government, visa or market-access outcome. Scope and deliverables are governed by separate signed agreements; final outcomes are subject to the relevant institutions, enterprises and regulatory requirements.

重要声明。AHIS 是立足澳大利亚的行业协会平台,非政府机构,亦不代表任何政府。会员、赞助及项目权益为交流机会、资源对接与介绍,是否提供以适配性及名额为准。AHIS 不提供医疗、法律、投资、税务或移民建议,不保证任何商业、监管(含 TGA / AHPRA)、投资、政府、签证或市场准入结果。具体范围与交付以单独签署协议为准;最终结果以相关机构、企业及监管要求为准。

Contact Us
联系我们

Get in Touch

欢迎与我们联系

Email

电子邮件

info@ahis-au.org

📍

Location

地址

Melbourne, Victoria, Australia

澳大利亚维多利亚州墨尔本

🏛️

Institutional Affiliation

关联机构

Mercury Institute of Victoria
CRICOS 03439M | RTO 41264
NPG New Pathway Group

维多利亚Mercury学院
CRICOS 03439M | RTO 41264
NPG新路径集团

🔗

链博会 Enquiries

链博会咨询

For delegation and MOU enquiries, email with subject: 链博会合作

链博会代表团及合作协议事宜,邮件主题请注明:链博会合作

Send an Enquiry

发送咨询